Leadership Overview
Sentiss Pharma Pvt has 4 executives leading key functions including strategy, financial oversight, human capital management, and investment analysis.
Focused on delivering high-quality ophthalmic and nasal solutions, Sentiss Pharma Pvt maintains a global commitment to innovative healthcare and rigorous quality standards while fostering a culture of excellence.
Focused on delivering high-quality ophthalmic and nasal solutions, Sentiss Pharma Pvt maintains a global commitment to innovative healthcare and rigorous quality standards while fostering a culture of excellence.
Leadership Roles at Sentiss Pharma Pvt
Deepak Bahri - Founder & Chief Executive Officer
Deepak Bahri, the Founder & Chief Executive Officer at Sentiss Pharma Pvt, directs the overarching strategic vision for the organization. This leadership role involves guiding the development of specialized ophthalmic, inhalation, and otic product lines to ensure global market competitiveness. By aligning research initiatives with patient health outcomes, the Founder & Chief Executive Officer drives the company toward long-term growth and innovation. Deepak Bahri maintains constant oversight of international expansion efforts, ensuring that the pharmaceutical portfolio meets stringent quality benchmarks across diverse regulatory environments. Through collaboration with the board and senior management, the Founder & Chief Executive Officer secures the necessary resources to scale manufacturing capabilities. This executive leadership ensures that the company remains a leader in niche pharmaceutical segments while upholding the core mission of delivering accessible, high-quality healthcare solutions to patients worldwide.
Debajit Sensharma - Chief Financial Officer
Debajit Sensharma, the Chief Financial Officer at Sentiss Pharma Pvt, manages the fiscal health and capital allocation strategies for the entire enterprise. Overseeing global financial planning and analysis, the Chief Financial Officer ensures that the company maintains the liquidity required to support complex pharmaceutical manufacturing operations. Debajit Sensharma directs the budgeting processes that fuel research and development for ophthalmic and nasal drop products. By monitoring market trends and economic shifts, the Chief Financial Officer mitigates financial risks associated with international trade and supply chain logistics. This leadership role involves providing the board with accurate financial reporting to facilitate informed decision-making regarding future investments. Through rigorous cost management and revenue optimization, the Chief Financial Officer strengthens the balance sheet, enabling the company to sustain its commitment to quality and social responsibility while achieving consistent profitability in the competitive pharmaceutical sector.
Joyeeta Chatterjee - Chief Human Resources Officer
Joyeeta Chatterjee, the Chief Human Resources Officer at Sentiss Pharma Pvt, architects the organizational culture and talent acquisition strategies that sustain the company's status as a top workplace. Overseeing employee engagement and professional development, the Chief Human Resources Officer ensures that the workforce remains aligned with the mission of delivering innovative healthcare solutions. Joyeeta Chatterjee directs initiatives that promote community engagement and internal satisfaction, which directly contribute to the company's recognition as a Great Place to Work. This leadership role involves designing performance management systems that reward excellence in manufacturing and research functions. By fostering an inclusive environment, the Chief Human Resources Officer supports the retention of top-tier talent necessary for maintaining high quality standards. Through strategic workforce planning, the Chief Human Resources Officer ensures that the organization possesses the human capital required to scale operations and meet the evolving demands of the global pharmaceutical market.
Sooraj Oswal - Cfa
Sooraj Oswal, the Cfa at Sentiss Pharma Pvt, evaluates investment opportunities and financial performance metrics to support the company's long-term growth objectives. Analyzing the profitability of the ophthalmic and inhalation product portfolios, the Cfa provides critical insights that guide capital expenditure decisions. Sooraj Oswal directs the assessment of market-specific financial risks, ensuring that the company maintains a robust position within the global pharmaceutical landscape. This leadership role involves collaborating with the finance department to optimize asset utilization and improve operational efficiency across manufacturing facilities. By conducting detailed financial modeling, the Cfa assists the executive team in identifying new avenues for revenue generation and market penetration. Through the application of rigorous analytical standards, the Cfa ensures that all strategic initiatives align with the company's commitment to fiscal responsibility and sustainable development, ultimately supporting the delivery of high-quality healthcare solutions to patients across various international regions.
Explore Leadership Teams in Manufacturing
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth-largest pharmaceutical company globally. The company discovers, develops, manufactures, and delivers medicines and vaccines with a research and development focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. GSK's product portfolio includes specialty medicines, vaccines, and general medicines targeting conditions such as HIV, respiratory diseases, cancer, immuno-inflammation, anti-viral, central nervous system disorders, metabolic conditions, cardiovascular disease, urogenital conditions, anti-bacterial treatments, dermatology, and rare diseases. The company also offers over-the-counter products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. In July 2024, the company moved its global headquarters to New Oxford Street in central London, positioning itself within the city's Knowledge Quarter near world-class science and academic institutions including the Francis Crick Institute and King's College London. The new headquarters houses approximately 3,000 employees including the global leadership team and teams supporting research and development, supply chain, commercial operations, and corporate functions. GSK sells its products through wholesalers, pharmacies, hospitals, physicians, and other healthcare groups globally, aiming to positively impact the health of 2.5 billion people by the end of the decade.
Company Leadership SN
SV
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.
Company Leadership
SM
CW
RT
Amgen Inc. (Nasdaq: AMGN) is a leading American multinational biotechnology company headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the biotech industry and remains at the forefront of scientific innovation.
Company Leadership SC
MC
Founded in 1987, Integrated DNA Technologies, Inc. headquartered in Coralville, Iowa, is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company develops, manufactures, and markets nucleic acid products for the life sciences industry.
Company Leadership AA
MM
AM
CL
Frequently Asked Questions Regarding Sentiss Pharma Pvt Top Executives and Leadership Team
